Additionally, in a study of in vitro and in vivo stroke models, the use of the Piezo1 agonist Yoda1 led to increased cell death, whereas the use of the Piezo1 antagonist GsMTx4 led to decreased cell death following hypoxia. Here, PIEZO1 is linked to Stroke.